{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:07:45Z","timestamp":1771636065130,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1245\/s10434-023-14448-6","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T21:01:40Z","timestamp":1697749300000},"page":"931-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Updated Outcomes from a Single-Institution Experience"],"prefix":"10.1245","volume":"31","author":[{"given":"Ahmed","family":"Halima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Fane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Fleming-Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Gentle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheen","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa","family":"Al-Hilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Tendulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"14448_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707\u201316.","journal-title":"Lancet."},{"key":"14448_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/OP.21.00635","volume":"17","author":"C Shah","year":"2021","unstructured":"Shah C, Al-Hilli Z, Vicini F. Advances in breast cancer radiotherapy: implications for current and future practice. JCO Oncol Pract. 2021;17:697\u2013706.","journal-title":"JCO Oncol Pract."},{"key":"14448_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.brachy.2019.01.015","volume":"18","author":"MC Tom","year":"2019","unstructured":"Tom MC, Joshi N, Vicini F, et al. The American Brachytherapy Society consensus statement on intraoperative radiation therapy. Brachytherapy. 2019;18:242\u201357.","journal-title":"Brachytherapy."},{"key":"14448_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","volume":"7","author":"C Correa","year":"2017","unstructured":"Correa C, Harris EE, Leonardi MC, et al. Accelerated partial-breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73\u20139.","journal-title":"Pract Radiat Oncol."},{"key":"14448_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.brachy.2022.07.004","volume":"21","author":"B Anderson","year":"2022","unstructured":"Anderson B, Arthur D, Hannoun-Levi JM, et al. Partial-breast irradiation: an updated consensus statement from the American Brachytherapy Society. Brachytherapy. 2022;21:726\u201347.","journal-title":"Brachytherapy."},{"key":"14448_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","volume":"22","author":"R Orecchia","year":"2021","unstructured":"Orecchia R, Veronesi U, Maisonneuve P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597\u2013608.","journal-title":"Lancet Oncol."},{"key":"14448_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383:603\u201313.","journal-title":"Lancet."},{"key":"14448_CR8","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/S0140-6736(14)60825-4","volume":"383","author":"J Cuzick","year":"2014","unstructured":"Cuzick J. Radiotherapy for breast cancer, the TARGIT-A trial. Lancet. 2014;383:1716.","journal-title":"Lancet."},{"key":"14448_CR9","doi-asserted-by":"publisher","first-page":"e200249","DOI":"10.1001\/jamaoncol.2020.0249","volume":"6","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, Bulsara M, Saunders C, et al. Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized clinical trial in early breast cancer. JAMA Oncol. 2020;6:e200249.","journal-title":"JAMA Oncol."},{"key":"14448_CR10","doi-asserted-by":"publisher","first-page":"m2836","DOI":"10.1136\/bmj.m2836","volume":"370","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, Bulsara M, Baum M, et al. Long-term survival and local control outcomes from single-dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ. 2020;370:m2836.","journal-title":"BMJ."},{"key":"14448_CR11","unstructured":"Bentzen SM HJ. No apparent effect of 50-kv intraoperative radiation therapy on locoregional control after lumpectomy for breast cancer. BMJ. (2020)"},{"key":"14448_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/tbj.13574","volume":"26","author":"E Obi","year":"2020","unstructured":"Obi E, Tom MC, Manyam BV, et al. Outcomes with intraoperative radiation therapy for early-stage breast cancer. Breast J. 2020;26:454\u20137.","journal-title":"Breast J."},{"key":"14448_CR13","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1245\/s10434-020-09432-3","volume":"28","author":"SA Valente","year":"2021","unstructured":"Valente SA, Tendulkar RD, Cherian S, et al. TARGIT-R (retrospective): 5-year follow-up evaluation of intraoperative radiation therapy (IORT) for breast cancer performed in North America. Ann Surg Oncol. 2021;28:2512\u201321. https:\/\/doi.org\/10.1245\/s10434-020-09432-3","journal-title":"Ann Surg Oncol."},{"key":"14448_CR14","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1245\/s10434-021-11295-1","volume":"29","author":"MJ Silverstein","year":"2022","unstructured":"Silverstein MJ, Epstein MS, Chen P, et al. Recurrence and survival rates for 1400 early breast tumors treated with intraoperative radiation therapy (IORT). Ann Surg Oncol. 2022;29:3726\u201336. https:\/\/doi.org\/10.1245\/s10434-021-11295-1","journal-title":"Ann Surg Oncol."},{"key":"14448_CR15","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613\u201326.","journal-title":"Lancet."},{"key":"14448_CR16","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.20.00650","volume":"38","author":"I Meattini","year":"2020","unstructured":"Meattini I, Marrazzo L, Saieva C, et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial. J Clin Oncol. 2020;38:4175\u201383.","journal-title":"J Clin Oncol."},{"key":"14448_CR17","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","volume":"394","author":"FA Vicini","year":"2019","unstructured":"Vicini FA, Cecchini RS, White JR, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised phase 3 equivalence trial. Lancet. 2019;394:2155\u201364.","journal-title":"Lancet."},{"key":"14448_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijrobp.2021.12.161","volume":"115","author":"MC Ward","year":"2023","unstructured":"Ward MC, Bentzen SM, Fasola CE, et al. An estimate of local failure in the TARGIT-A trial of pre-pathology intraoperative radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 2023;115:73\u20136.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"19","key":"14448_CR19","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382.","journal-title":"J Clin Oncol"},{"key":"14448_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"IH Kunkler","year":"2023","unstructured":"Kunkler IH, William LJ, Jack WJL, et al. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388:585\u201394.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14448-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:21:36Z","timestamp":1704208896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14448-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["14448"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14448-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chirag Shah, MD is a consultant for ImpediMed, PreludeDX, and Videra Surgical, and received grants from Varian Medical Systems, VisionRT, and PreludeDx. Stephanie Valente serves on the advisory board for Impedimed and is a consultant for AxoGen. Rahul Tendulkar received honoraria for educational talks from Varian Medical Systems, a manufacturer of linear accelerators. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}